Join Labcorp at World CB & CDx | Sept. 22–25
Accelerate precision medicine for greater patient access to your breakthrough therapy
Labcorp delivers comprehensive support across the precision medicine journey—from biomarker discovery and clinical trial assay development to CDx commercialization and global patient testing.
Discover how we can support your studies across testing modalities and therapeutic areas with
- Strategic guidance from our Biomarker Solution Center to inform development
- Collaborative CDx programs with regulatory and diagnostic specialists
- Sample-to-answer precision oncology services across our international laboratory network
Meet us at World CB & CDx to explore how Labcorp helps bring your groundbreaking therapies to more patients, faster.
Not registered yet? Biopharma leaders can register for free.
Join our session explore how aligning science, trials, and strategy can de-risk CDx development and drive commercial success.
Thursday, Sept. 25, 2025 | 8:30AM | Location TBD
Precision-driven CDx: Real-World Insights to Align Science, Trials, and Strategy
Speaker: Alan Arnold, Scientific Director, Precision Medicine, Diagnostic Development Services
Developing a companion diagnostic (CDx) is complex, with risks spanning scientific uncertainty, regulatory hurdles, and commercial viability. This session explores real-world case studies in oncology and emerging therapeutic areas, showing how to de-risk your CDx strategy and build smarter from the start.
Attendees will learn how to:
- Leverage early biomarker insights and flexible planning for timely CDx investment decisions
- Align therapeutic and diagnostic timelines to ensure global regulatory readiness
- Use harmonized lab operations and centralized platforms (genomics, flow, APH) for consistent data and insights
- Enable patient access through custom assay development, validation, approval, and launch